XWELL, Inc. received a formal notice from The Nasdaq Stock Market LLC on October 7, 2026, stating that the company failed to meet the minimum bid price requirement for continued listing. The notification cites the closing bid price of XWELL common stock over a 30-business-day period from August 25, 2026, through October 6, 2026, which fell below the mandated threshold.
Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share. Because XWELL did not satisfy this standard during the specified review period, the Nasdaq Listing Qualifications staff issued the deficiency notice. The company is now required to take specific steps to restore compliance within a set timeframe.
Under Nasdaq Listing Rule 5810(c)(3)(A), XWELL has been granted a compliance period of 180 calendar days, expiring on April 5, 2027. To regain compliance, the closing bid price of the common stock must reach at least $1.00 per share for a minimum of ten consecutive business days during this period. The Nasdaq staff retains discretion to require a longer compliance duration if necessary. Alternatively, the company may implement a reverse stock split to meet the price requirement, though any such action must be completed no later than ten business days before the April 5, 2027 deadline.
The notice outlines severe consequences if XWELL fails to act. If the closing bid price drops to $0.10 or less for ten consecutive trading days during the compliance period, Nasdaq will issue a Staff Delisting Determination immediately. If the company does not regain compliance by April 5, 2027, it may qualify for an additional 180-calendar-day compliance period. Eligibility for this extension depends on meeting other continued listing requirements, including the market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, excluding the bid price rule. The company must also provide written notice to Nasdaq of its intention to cure the deficiency during this second period.
If XWELL is not eligible for an additional compliance period or fails to regain compliance within the applicable timeframe, Nasdaq will provide notice that the common stock will be subject to delisting. Any delisting determination can be appealed to a Nasdaq Hearings Panel in accordance with applicable listing rules.
The notice has no immediate effect on the trading of XWELL shares. The stock continues to be listed and traded on The Nasdaq Capital Market under the symbol XWEL, subject to compliance with other continued listing requirements. Management plans to track daily closing prices and evaluate potential strategies to meet the bid price standards. However, the company noted that there can be no assurance it will regain compliance within the applicable period.
The Form 8-K filing includes forward-looking statements regarding the company's ability to meet Nasdaq rules, including through a possible stock split or eligibility for an additional compliance period. These statements are based on current expectations and are subject to risks and uncertainties beyond the company's control, such as market conditions and regulatory developments. XWELL undertook no obligation to update these statements except as required by law. The report was signed by Ezra T. Ernst, President and Chief Executive Officer, on October 20, 2026.